
KNSA Market Capitalization Overview
Market Cap: $3.24B as of Jan 9, 2026
$3.24B
$115.97M (3.72%)past month
As of Jan 9, 2026, KNSA has a market capitalization of $3.24B. Over the past 30 days, its market cap has increased by 2.63%, while in the last 12 months, it has increased by 3.44%.
Market capitalization represents the total value of Kiniksa Pharmaceuticals Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
KNSA Market Cap Formula = Stock Price * Shares Outstanding
The market cap of KNSA helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Kiniksa Pharmaceuticals Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
KNSA Market Cap Formula = Stock Price * Shares Outstanding
The market cap of KNSA helps investors assess the company's size and compare it with competitors for better investment decisions.
KNSA Market Cap & Key Trends
See Kiniksa Pharmaceuticals Ltd’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in KNSA
Order type
Buy in
Order amount
Est. shares
0 shares
KNSA Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $3.11B | +9.23% |
| Nov 3, 2025 | $2.85B | -0.82% |
| Oct 1, 2025 | $2.87B | +12.72% |
| Sep 2, 2025 | $2.55B | +7.19% |
| Aug 1, 2025 | $2.37B | +19.23% |
| Jul 1, 2025 | $1.99B | -2.44% |
| Jun 2, 2025 | $2.04B | +0.68% |
| May 1, 2025 | $2.03B | +27.96% |
| Apr 1, 2025 | $1.59B | +1.44% |
| Mar 3, 2025 | $1.56B | +14.36% |
| Feb 3, 2025 | $1.37B | -5.32% |
| Jan 2, 2025 | $1.44B | -8.74% |
KNSA End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $3.24B | +3.44% |
| 2025 | $3.13B | +118.93% |
| 2024 | $1.43B | +15.76% |
| 2023 | $1.24B | +18.45% |
| 2022 | $1.05B | +28.46% |
| 2021 | $810.82M | — |
FAQs About Kiniksa Pharmaceuticals Ltd (KNSA) Market Cap
As of Jan 9, 2026, the market capitalization of KNSA is $3.24B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Kiniksa Pharmaceuticals Ltd’s market capitalization has increased by 3.72%, changing from $3.12B to $3.24B as of Jan 9, 2026.
In the last 3 months, Kiniksa Pharmaceuticals Ltd’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Kiniksa Pharmaceuticals Ltd’s market capitalization increased from $1.43B in January to $3.13B in December, reflecting a 118.93% change.
In the past five years, KNSA has had a compound annual growth rate (CAGR) of 30.99% in market capitalization. This means its market cap has grown at an average rate of 30.99% per year.